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Abstract
Introduction: The incidence of abdominal aortic aneurysms has been increasing through-
out the world. The etiology and pathophysiology of this disease are very complicated and
complex and include biomechanical aspects as well as biological processes. The effect of
these mechanisms is the degradation of the aortic wall, which leads to its dilation and
rupture. The possibilities for studying such complex pathophysiology in humans are very
limited. That is why we use various mathematical models and a number of different
animal models of aneurysm. Methods: A summary of the basic characteristics, findings
and examples of using the most widely used animal models of abdominal aortic aneu-
rysm. Information has been obtained from our own experience with laboratory animals
and from studies published and available on the Pubmed Internet database. The following
search terms were used: aneurysm, aorta, animal model and experiment. Conclusion:
Animal models of aortic aneurysms are a usable and useful tool in the study of AAA
etiopathogenesis. They also serve as a means to find novel therapeutic pathways. Each
model, like any animal species, is different and has its own limitations, advantages and
disadvantages, which we should always consider during their use and while interpreting
the results.
Keywords: experiment, aneurysm, aorta, animal, model
1. Introduction
1.1. Introduction
Infrarenal aortic aneurysm is a disease, which puts patients at risk primarily due to its long,
asymptomatic course, often resulting in abrupt pain caused by rupture as the first sign of the
disease [1]. Aneurysmal rupture often has a fatal outcome. Infrarenal aortic aneurysm is not a
single group of diseases. The etiology is different in patients with congenital connective tissue
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disorders in Marfan syndrome and Ehlers-Danlos syndrome [2], different in infectious aneu-
rysms with bacterial agents clearly confirmed by culture [3] and different in aneurysms classi-
fied as degenerative [4], which represent the most common ones. These are diseases with
etiology that has not been completely elucidated. The pathophysiology of aneurysmal devel-
opment is a very complex process with complicated interrelated and interconnected physical
and biological mechanisms that lead to the degradation of the molecular and cellular structure
of the vessel wall [4]. It is exactly this complicated and not yet fully elucidated etiopathogenesis
that makes aneurysms the subject of continued interest across scientific disciplines. One of the
options to study the individual processes at different levels are animal models and experimen-
tal animal research. Animal models, unlike aneurysm samples obtained from surgery or
autopsy, are used to study the individual mechanisms from the early stages of aneurysmal
development. Studies in humans are conducted to examine the changes at an advanced stage.
Experimental work with animals requires strict adherence to the rules, careful planning and a
lot of effort. The advantage is the possibility to see the individual processes and mechanisms in
the context of the whole body, including all interactions.
1.2. Materials and methods
This chapter gives a summary of basic characteristics of most commonly used animal models
of aortic aneurysms. By giving few examples of each model, it also points out the advantages
and disadvantages and their practical application. The authors gain the information from
published studies that are available on the Pubmed Internet database. For searching in the
database, the words experiment, aneurysm, aorta, animal and model were used. Only those
papers were read and accepted, if the full text was written in English. Another source of
knowledge presented in this chapter is a long-time experience and practice with laboratory
animals of different species in various models and studies on the authors’ place of work. Due
to the nature of this chapter and many variables, no statistical analysis is presented.
2. Experimental work and models of AAA
2.1. General conditions for working with laboratory animals
The current issues of experimental work with animals are subject to European and global
conventions on the protection of animal rights, which may be further regulated and specified
by national legislations. Several fundamental rules apply in this field. In general, there have
been attempts to reduce the total number of animals used for experimental purposes. The
interests of researchers may be in conflict with those of animal rights defenders and a reason-
able compromise should be sought. The conditions in which the animals are kept, how they
are treated during transportation and throughout the experiments, including the killing and
subsequent handling of the remains, have been constantly improved. The basic principles and
rules of working with experimental animals, which are valid still today, were defined by
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William Russell and Rex Burch in the mid-twentieth century in the book “The Principles of
Human Experimental Technique” [5]. They can be summarized in three points or rules known
as “3R”—Replacement, Reduction, Refinement [6].
Replacement: an effort to find other, alternative methods of conducting research without the
use of laboratory animals. When considering the initiation of research, we should first ask and
answer the question of whether it is possible to obtain the result without using laboratory
animals. The current level of knowledge allows the use of a variety of mathematical or
computer models. Cell or tissue cultures alone can often be used to verify hypotheses. If this
is not possible, we should always try to use animals from lower evolutionary groups. If work
with animals is a part of teaching programs, it can often be replaced by video recordings.
Reduction: an effort to reduce the total number of laboratory animals used. This rule is closely
related to the previous one. The already mentioned use of nonanimal models and cell and
tissue cultures should include the careful planning of experimental work so that we do not
duplicate experiments that have already been carried out unnecessarily or do not verify
hypotheses that have already been adequately verified. The total number of laboratory animals
used can be reduced by appropriate selection of the animal species, choice of appropriate sex
and age. Careful consultation with the statistician (appropriately chosen model, number of
animals in each group, length and ways of monitoring) should be an integral part of the
planning.
Refinement: includes measures to improve the living conditions and the environment of
laboratory animals. Working with laboratory animals requires the possession of authorizations
that can be obtained based on professional education and experience. The Federation of
European laboratories animal science associations (FELASA) determines four categories of
authorization (A-D) according to the level of education and length of practice. Correct or
wrong animal handling can significantly affect the results of the experiment. Any handling of
animals, including transportation and environmental changes, is stressful for animals. In
addition to stress, transportation also poses the risk of the transmission of infections not only
to the animal but also to the transporter, and it is therefore necessary to choose suitable
transport boxes (air conditioning, protection). Acclimatization to the new environment is
always necessary between transportation and the beginning of the experiment. The acclimati-
zation time varies according to the type of animal chosen and also serves to normalize changes
caused by stress during transportation (weight loss, change in heart rate). The environment in
which the animal is kept (box size, number of animals in the box, temperature, humidity,
observation of circadian rhythm, appropriate feeding) and how the animal is treated is very
important. Smaller laboratory animals are less expensive, and handling them is not so physi-
cally demanding and does not require much space. On the other hand, greater size of the
animals, such as a rabbit or a pig, may be an advantage when handling organs and tissues.
Any painful handling, investigations, and procedures should be performed under anesthesia,
and suitable analgesia should be provided, including in the postoperative period. The method
of anesthesia should be selected according to the type of animal chosen and plays an important
role in the successful completion of the experiment and achievement of the necessary results.
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The anesthesiologist should be sufficiently experienced and knowledgeable about the specific
differences of the chosen animal species.
Strict adherence to the established rules and standardized conditions is an inherent part of any
experimental work so that the results of the work are reproducible, repeatable and the statis-
tical analysis is valid.
At present, multiple animal species are used in animal experiments. The same is true for
experimental works related to aneurysms. Wild-type (WT) animals, whose genome is not
modified, can be used for each animal species. Interindividual differences, for example, in
enzymatic activity are a certain disadvantage when studying such populations [7]. This is one
of the reasons why genetically modified strains of animals are often used in studies in which a
population of similar or virtually identical animals is being studied [7]. Another advantage of
using modified strains is a specific modification that allows for the monitoring of, for example,
the involvement of a particular enzyme and its activity in the studied process. Especially in
mice, a large variety of different genetically modified strains are available. With a properly
chosen animal, we are able to model very specific situations. A properly chosen animal type
and methodology can significantly influence the results of the work in both positive and
negative terms, as documented below in the text. When choosing an animal model, it is
necessary to answer the question of whether it will be possible to compare the model with the
real situation in human medicine and to what extent the conditions studied will be similar
(enzymatic equipment etc.) or different from the reality.
2.2. Animal models of AAA
Animal aneurysm models help clarify the complex etiopathogenesis, can be used to develop
new treatment methods or to improve endovascular and surgical procedures. The first animal
aneurysm models were published in the 1960s, and many other methods and models have
been developed since then and have been variously upgraded and improved [8–11]. In princi-
ple, the methods of inducing an aneurysm in animals can be divided into those using different
chemicals and those using physical laws and their various combinations. Papers that are
presenting research with different models of aneurysm and different animal species are sum-
marized in Table 1.
2.2.1. Elastase model
Perhaps the most important changes that can be observed in the aneurysm wall in humans are
degeneration of extracellular matrix—degradation of elastin in the presence of matrix
metalloproteinases 1, 2, 3 and 9 (MMPs) and the inflammatory infiltration. The first attempts
to develop an experimental aneurysm used proteolytic enzymes to cause the degradation of
elastin fibers. Wills et al. [8] used porcine aortic tissue to demonstrate the effect of exogenous
elastase in the development of degenerative changes of the extracellular matrix. He confirmed
the results and observations attained by Anidjar et al. [21]. Anidjar repeatedly demonstrated
the possibility of establishing an aortic aneurysm model in rats by applying porcine pancreatic
elastase (PPE). Anidjar’s model represents the basis for a various PPE model modifications. In
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this model, a segment of infrarenal aorta is perfused with a PPE solution through a directly
inserted tube or needle. The authors and models can differ in the concentration of PPE,
method of perfusion (pump, single or repeated applications, or application with increased
pressure), duration of perfusion and the laboratory animal [24–26, 28, 52]. Anidjar perfused a
1 cm long segment of aorta of rat with a porcine elastase solution. Other proteases (papain,
trypsin, and collagenase) can lead to the development of an aneurysm as well. Carsten et al.
[23] studied several batches of elastase and confirmed the need for inflammatory infiltration
with activated macrophages to achieve the necessary extracellular matrix degradation and
Model Animal Study Additional
information
PPE Mice Pyo et al. [12], Moore et al. [13], Bigatel et al. [14], Curci et al. [15],
Boyle et al. [16]
Bhamidipati et al. [17] Periadventitial
apply
Zhou et al. [18], Johnston et al. [19], Parodi et al. [20] Genetically
manipulated
Rat Holmes et al. [21], Anidjar et al. [22], Carsten et al. [23], Dobrin
[24], Azuma et al. [25], Yamaguchi et al. [26]
Dog Strindberg et al. [27], Economou et al. [28]
Yucatan miniature
swine
Marinov et al. [29]
Rabbit Nie et al. [30], Bi et al. [31], Kobayashi et al. [32]
CaCl2 Rabbit Gertz et al. [9], Freestone et al. [33]
Mice Chiou et al. [11], Watanabe et al. [34]
Basalyga et al. [35] Genetically
manipulated
Rat Gacchina et al. [36]
Angiotensin II Apolipoprotein E
deficient mice
Daugherty et al. [10], Wang et al. [37], Saraff et al. [38], Inoue et al.
[39], Rateri et al. [40], Briones et al. [41]
Zebrafish Folkesson et al. [42]
Stenosing cuff Rat Mata et al. [43]
Patch Minipig Lin et al. [44]
Tissue
transplantation
Rat/Hartley guinea
pig
Allaire et al. [45], Schneider et al. [46]
Combined Rat Tanaka et al. [47], Morimoto et al. [48] PPE + CaCl2
Pig Moláček et al. [49] PPE/stenosis/
patch
Houdek et al. [50] PPE + stenosis
Turnbull et al. [51] PPE + balloon
dilatation
Table 1. Animals and models of experimental aneurysm used in presented studies.
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aneurysmal development in rats. PPE model was widely used to study the pathophysiology
and possible treatment options of AAA. For this purpose, genetically modified mice were used
[12] and many anti-inflammatory acting drugs and agents were studied (TIMPs, doxycycline,
indomethacin) [13–16, 21]. Periadventitial application of elastase in mice may cause similar
changes and lead to development of AAA as well [17]. Nie et al. [30] induced an aortic
aneurysm using PPE in the New Zealand White Rabbit within 14 day. Despite mild differences
in the method of perfusion, similar conclusions were made by Bi et al. [31] and Kobayashi et al.
[32]. Both used higher pressure for the perfusion. In elastase-induced models small animals are
commonly used. In large animals, such as different species of pigs or in dogs, the results are
not so unambiguous. Marinov et al. [29] observed elastin fiber destruction, inflammatory
infiltration, a change in wall thickness and changes in smooth muscle cells, and even calcium
depositions after aortic perfusion with PPE in Yucatan miniature swine, but he did not observe
the development of aneurysmal dilation after 3 weeks. Strindberg et al. [27] wanted to use the
elastase-induced aneurysm model in a dog for control and development of stent grafts. He
compared the changes while using different elastase concentrations, different perfusion times,
and the combined use of elastase with collagenase and/or an inflated intraluminal balloon
catheter. By extending the perfusion time to 2 h and using elastase alone or in combination
with collagenase, aortic dilation of 65.6  20.8% was present, which was not enough for his
need. Degradation of elastin fibers, a reduced number of smooth muscle cells and an intimal
thickening were present during the examination of the aorta samples. Many modifications of
the elastase-induced aneurysm model employ differently genetically modified and specified
animal clones [18–20].
2.2.2. Calcium chloride model (CaCl2)
Inflammatory infiltration is another significant contributor to the development of aneurysms.
This reaction can also be induced by an external insult to the adventitia. The use of calcium
chloride to induce an aneurysm was first described in the carotid arteries of rabbits [9] more or
less as a secondary observation. However, the histological structure of these aneurysms some-
what differs from findings in human aneurysms. In both cases, we can see changes in the
media with wall thickening and inflammatory reaction, but in carotid artery aneurysms in
rabbits, the wall thickening is more pronounced with marked intimal hyperplasia and marked
calcification of elastin fibers in the media. For the abdominal aorta, this methodology and
experience was described by Freestone et al. [33]. He studied the effects of different concentra-
tions of calcium chloride and sodium chloride solutions applied to the surface of the infrarenal
aorta for 15 min. He also examined the possibility of influencing the effect of calcium chloride
by added sodium thioglycolate and a high-cholesterol diet. Histological changes (intimal
hyperplasia, media injury, calcification of the media) increased with the increasing calcium
chloride concentrations. The leading symptom was infiltration of the media and adventitia by
macrophages and increased activity of MMP2 and 9. Aneurysms developed at a concentration
of 0.25 mol/L. High cholesterol and/or thioglycolate levels did not significantly affect the
development of aneurysms. The effect of sodium chloride has not been demonstrated as well.
Chiou et al. [11] provided a similar comparable study but he used mice as a laboratory animal.
Calcification of the vascular wall is a common denominator of a number of vascular diseases.
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We can find calcification in the aortic and aneurysm walls. Basalyga et al. [35] used the
application of calcium salts at various concentrations in unmodified and genetically
engineered mice to verify the association of elastin degradation caused by the action of MMP
and the resulting calcification. Watanabe et al. [34] used genetically engineered mouse clones
with calcium chloride-induced aneurysm for studying the role of phospholipase A2 (PLA2)
and inflammation in the pathogenesis of AAA. Other study confirmed a protective effect of
PLA2 inhibitor. Using the calcium chloride-induced aneurysm model in mice, Gacchina et al.
[36] referred the role of vascular smooth muscle cells (VSMC) for the AAA growth.
2.2.3. Angiotensin II model
Like previous aneurysm models, another model that uses the effect of angiotensin II has
several common characteristics with human aneurysms. It is an association with hyperlipid-
emia, wall remodeling, inflammation and thrombosis and also a higher incidence in males [53].
The model is more animal-specific and uses apolipoprotein E deficient mice (ApoE /).
Daugherty et al. [54] examined the effect of Angiotensin II on the development of atheroscle-
rosis in relation to hyperlipidemia. He administered angiotensin II to ApoE / clones of mice
for 1 month using a minipump. In addition to the development of atherosclerotic changes,
both by the action of higher blood pressure and independent of elevated blood pressure on the
basis of activation of the monocyte-macrophage system and oxidative stress, Daugherty
observed development of aneurysm as a secondary effect. This phenomenon was not depen-
dent on blood pressure or lipid levels or their distribution in the blood. The mice thus treated
were found to have a number of macrophages and lymphocytes, that is, inflammatory infiltra-
tion in the external elastic lamina and adventitial hypertrophy. In contrast to human aneurysm,
the effects of angiotensin II result in dilation and development of aneurysm in the suprarenal
segment [10]. This is explained by a higher proportion of fat cells in the adventitia region in the
suprarenal segment of the aorta. Dissection and rupture have been reported to occur more
frequently [38, 39]. In animals, rupture of the media occurs with thrombus formation and
further stimulation and activation of macrophages with elastin disintegration and matrix
remodeling. The described changes and the rate of aortic dilation are not the same in identical
animals even under the same experimental conditions [10, 37]. Based on these differences, four
subtypes of angiotensin II-induced aneurysm models can be distinguished. This heterogeneity
can also be observed when comparing samples from different levels of aneurysm in one
animal [40]. In this model, further growth of the aneurysm occurs for several weeks after the
last angiotensin infusion [39]. Another animal that was used as an angiotensin-induced aneu-
rysm model was the zebrafish. This is primarily due to similar vasculogenesis with humans
[42]. This model was used primarily to investigate the effects of smoking tobacco.
2.2.4. Combined and other newer models
Very often, experimental aneurysm models combining the effects of calcium chloride and
pancreatic porcine elastase are used. These models are often associated with rats. As an
example, we can mention the Tanaka group [47], who achieved aneurysmatic dilation in
almost 93% of animals by using the combined approach, but only in 25% and 0% of animals
when using PPE alone or CaCl2 alone, respectively. Even histological changes copied this
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trend: less elastin, more pronounced infiltration by inflammatory cells, and higher activity of
cytokines and MMPs 2 and 9 were recorded in the group combining the effects of PPE and
calcium chloride. Morimoto et al. [48] used this combined model in rats to study the effects of
free oxygen radicals. Molacek et al. [49] compared different AAA animal models in pigs. He
compared the PPE model, stenosing cuff model, Dacron patch model and their combinations.
He observed best results in combination of PPE model with hemodynamical changes caused
by a stenosing cuff placed around the subrenal aorta (p < 0.0156) and the same group used this
knowledge to influence the growth of experimentally created aneurysm in rats and pigs with
atorvastatin [50]. They observed no thrombus, lipid deposition, media necrosis, intramural
hematoma, dissection, or rupture in this combinedmodel. Figures 1–3 show the combination of
placed stenosing cuff and PPE infusion and the aortic dilatation after 4 weeks in pig. Figures 4
and 5 are images from ultrasound, showing dilatation of porcine infrarenal aorta after 2 weeks.
Figure 1. Porcine infrarenal aorta with stenosing cuff day 0. Black arrow—stenosing cuff; yellow arrow—infrarenal aorta;
blue arrow—aortic bifurcation; red arrow—inferior caval vein.
Figure 2. Infusion of clamped infrarenal aorta with porcine pancreatic elastase day 0.
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Another models that combine the use of PPE, CaCl2 or Angiotensin II in mice, rats, rabbits or
pigs were used to explain the effects of various statins and other drugs [41, 55–60].
The possibilities of using stem cells to influence the growth and rupture of aneurysms have
been increasingly studied in recent years. This topic is studied by many authors and no
consensus has been achieved as to the optimal experimental model or laboratory animal.
Mesenchymal stem cells (MSCs) have been used in studies to treat a number of cardiovascular
diseases, such as critical limb ischemia, cerebral ischemia or myocardial infarction. It is
believed that mesenchymal stem cells (MSCs) could help to inhibit degenerative changes in
the AAA wall and promote its regeneration. Turnbull et al. [51] attempted to demonstrate the
uptake and the presence of stem cells in the aortic wall after insult. She used an experimental
pig model, where she combined physical (balloon dilation) and chemical (the effect of PPE and
collagenase) methods, and administered stem cells to the pigs. Her methods have led to the
Figure 3. Dilatation of porcine infrarenal aorta. Combined model—stenosing cuff + PPE. Day 28. Black arrow—stenosing
cuff; yellow arrow—dilated infrarenal aorta; blue arrow—aortic bifurcation; red arrow—inferior caval vein.
Figure 4. Ultrasound image of dilated porcine infrarenal aorta. Translumbal approach. Transverse view. Day 14. Com-
bined model—stenosing cuff + PPE. Yellow arrow—dilated infrarenal aorta; red arrow—inferior caval vein.
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development of aneurysms with characteristics close to human ones, such as expression of
MMP2 and 9. By proving the presence of stem cells in the affected aortic wall, she verified her
hypothesis and provided the basis for further research. Regeneration of the damaged aortic
wall largely depends on the capabilities and presence of VSMC. Schneider et al. [46] was able
to improve the regeneration of the aortic wall and thereby influence the progression of aortic
dilation in the negative sense using mesenchymal stem cells with a wide differentiation capac-
ity. The effect of MSC was greater than that of VSMC alone. In his work, he induced aneurysms
in rats by implanting an aortic graft from guinea pigs. Before the implantation, the xenografts
were perfused with a solution containing VSMC or MSC or with a cell-free solution in a control
group. The development of aneurysms occurred 14 days after. Grafts colonized by MSC
showed significantly less dilation after 1 and 4 weeks compared to those colonized by VSMC
and to the controls, where further dilation occurred (p = 0.006). The presence of MSC led to a
reduction in inflammatory cell infiltration, a decrease in activity of MMPs, increased TIMP-1
activity, and triggered regeneration of the damaged aortic wall.
3. Discussion
Experimental studies have an irreplaceable role in a research of etiopathogenesis and possible
treatment options of AAA. Experimental works with animals and aneurysm models, in con-
trast to human aneurysms, allow us to monitor the development of aneurysms over time and
take samples for analysis at any time during the development. Exploitation of experimental
animal models provides, beyond the research of etiopathogenesis, a wide range of possibilities
for studying therapeutic interventions, influencing growth or preventing aneurysmal develop-
ment and rupture. Pharmacotherapy used in experimental models is strongly influencing the
initial changes and triggers, and in some models, even a pretreatment is used. To better
understand the etiopathogenesis of infrarenal aortic aneurysm, especially how to prevent the
Figure 5. Ultrasound image of dilated porcine infrarenal aorta. Translumbal approach. Longitudinal view. Day 14.
Combined model—stenosing cuff + PPE. Black arrow—stenosing cuff; yellow arrow—dilated infrarenal aorta; blue
arrow—aortic bifurcation; red arrow—inferior caval vein.
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growth and rupture, comprehensive studies are needed. Triggers and initial steps leading to
the development of aneurysms in animals under experimental conditions are known. Studies
with animal AAA models have promising results, but if they are repeated in humans, the
results are inferior. The models are representing “acute” aneurysms. Aneurysms in humans
are growing slowly usually with degenerative changes. Degenerative aneurysms usually
develop in humans over many years. For animal models, this time is significantly shorter,
ranging from days to weeks. There are differences not only between animal AAA model and
AAA in human, but also various changes in the results, if a different animal species or different
AAA model is used. Table 2 summarizes the advantages and disadvantages of each model.
Not all animal aneurysm models are capable of achieving sustained growth and dilation, and
ruptures of already existing aneurysms cannot be observed in all models. Specifically, no
ruptures were observed in models with calcium chloride alone. The presence of thrombus in
the aneurysm is common in the human aorta, but thrombus formation does not occur in most
animal models. Common for majority of animal AAA models is the degradation of extracellu-
lar matrix and elastin fibers, increased MMP activity and inflammatory infiltration of aortic
wall.
The angiotensin II model is, to a certain extent, very specific not only due to the choice of
animal (apolipoprotein deficient mouse clone), but in contrast to other models, the aortic
dilation occurs predilectively, in the suprarenal region, and more than other models encoun-
ters dissection and rupture, and the development of dilation may be less predictable.
The use of PPE alone to induce aneurysm model is effective in small animals (mouse, rat), can
be used in large animals (rabbit, pig, dog) as well, but in large animals, this model is less
effective. With respect to the proven and dominant changes in the wall of such aneurysms
(inflammatory infiltration, degradation of elastin fibers, increased MMP activity), which are
more or less consistent with the changes that can be observed in human aneurysms, such
model can be considered to be appropriate. It has been used extensively to study possible
Model Advantage Disadvantage
PPE Possible in majority of animal species Surgery
Good results in small animals AAA development within 2–4 weeks
Less effective in big animals
CaCl2 Possible in majority of animal species Surgery
Common in combined models No rupture has been observed
Widely used with knockout mice AAA development within 2–4 weeks
Angiotensin II Shorter time for development Apolipoprotein E deficient mice
Common rupture Dilatation of suprarenal aorta
Stenosing cuff/patch Shorter time for development Difficult in small animals
Tissue transplantation Common thrombus Difficult surgery
Table 2. Advantages and disadvantages of different models of experimental aneurysm.
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prophylactic and therapeutic methods and to explore the individual pathogenetic mechanisms
of aneurysmal development. PPE can also be used to study isolated aortic tissue.
Small animal—mice is commonly used for the calcium chloride-induced aneurysm model as
well. Changes and characteristics are comparable to human. It is most often used in the
infrarenal region; the aneurysmatic wall contains calcifications with inflammatory cellular
infiltration. Oxidative stress, degradation of elastin fibers and changes in SMC play role in this
model. In addition, the mechanisms involved in the induction of aneurysms in this model
appear to be involved in the pathogenesis of aneurysm in humans, for example, sPLA2 and
plasminogen. Unlike human aneurysms, no rupture, intraluminal thrombus or atherosclerotic
changes other than calcification have been observed in this model. Studies have confirmed that
this model can be used in both WT animals as well as in genetically modified animals. This
aneurysm model is perhaps more often used in combination with other techniques of aneu-
rysm modeling in different animal species.
Most of the models described herein were used in more than one animal species. The advan-
tage of larger laboratory animals, such as pigs or rabbits, is their size and hence the size of the
aorta, which improves tissue handling. On the other hand, the size itself may also be a
disadvantage in terms of spatial capacity and handling of the animal itself. The pig has an
anatomy and physiology generally similar to humans, which is undoubtedly important for
interpreting the results and possible use in human medicine. If we select a mouse as a labora-
tory animal, we have the option of choosing wild species or a variety of genetically modified
strains. Lower financial burden is certainly a great advantage of small laboratory animals. In
any case, adequate methods of application and administration of pharmaceutical doses should
be observed for the selected laboratory animal and aneurysm model. We have mentioned
contrast between animal models and the real human aneurysm.
Examples were included for all the abovementioned animal models of AAA, where the possi-
bilities of positive pharmacological effects on aneurysm growth and potential rupture were
studied. The effects of drugs should be first verified in laboratory animals or in tissue culture
and afterwards in a clinical trial.
4. Conclusion
Animal models of AAA are still essential in searching for novel treatment options. Successful
aneurysm induction depends on the choice of the right laboratory animal in each method. In
general, small laboratory animals are preferred in experimental studies. Small animals are
cheaper, handling with them is easier and they require less space. This enables to design trials
with more individuals. There are different genetically modified mouse clone available on the
market and that makes mouse a widely used laboratory animal. Regarding current experi-
ences, no universal animal AAA model can be recommended. The aim of the study, advan-
tages and disadvantages of each model should be taken into consideration when preparing the
design of a new study. The most commonly observed features of various animal models and
human aneurysms are the presence of cellular inflammatory infiltration in the aortic wall,
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degradation of the elastin fiber network, increased activity of MMP2 and 9, and a lower
number of smooth muscle cells, but many differences and contrasts are observed as well.
Because of these contrasts, each observation and result of animal study have to be confirmed
in clinical study before they can be implanted into daily medical practice. Unfortunately, ideal
model similar to human’s AAA remains undeveloped.
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